Vimarsana
Biggest News Aggregation in the World

Philipp Spycher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipp Spycher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipp Spycher Today - Breaking & Trending Today

Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024 - Vimarsana News

Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024

AU ZH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- Araris Biotech AG ("Araris" or "the Company"), a company pioneering a proprietary antibody-drug conjugate (ADC)- technology, today announced the company will

Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator - Vimarsana News

Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator

Innosuisse supports 53 companies out of 752 applications with total CHF 112MAraris’ awarded grant will be used to support further development and...

Araris Biotech Receives CHF 2.5M Grant Funding - Vimarsana News

Araris Biotech Receives CHF 2.5M Grant Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Samsung Ventures invests in Araris Biotech in emerging ADC strategy - Vimarsana News

Samsung Ventures invests in Araris Biotech in emerging ADC strategy

Samsung Ventures, the global investment arm of Samsung Group, has invested an undisclosed amount in the Swiss company Araris Biotech. The deal is independent from Araris’ ongoing Series A fundraising and will be used to bankroll the development of antibody-drug conjugates for cancer.

Samsung Biologics, Samsung C&T invest in Araris Swiss biotech company - Vimarsana News

Samsung Biologics, Samsung C&T invest in Araris Swiss biotech company

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.